Breaking Ground in Equine Healthcare: The Launch of AgmaVet® For Horses

In a development poised to revolutionize equine health management, Gilad&Gilad has introduced **AgmaVet® For Horses**. This product is a nutraceutical supplement that leverages the prowess of the neuroprotective ingredient **G-Agmatine®**. Designed to bolster nerve functions, it also aims to reduce joint discomfort in horses, a vital concern in the equine community. Let's explore the details of this innovation and how it can transform equine care.

Tackling Osteoarticular Issues

Horses, known for their strong and swift movements, ironically face significant challenges with **osteoarticular issues** such as osteoarthritis (OA). These health concerns usher in lameness and hefty economic setbacks, with industry losses pegged at around **$1 billion annually**. Traditional interventions prioritize joint improvement but often neglect nerve function, leading to inconsistent outcomes. The side effects, including gastric ulcers, further complicate matters. Herein lies the significance of AgmaVet® For Horses, offering a comprehensive solution targeting both nerve resilience and joint mobility in equines.

Scientific Solidarity in Support

Scientific research offers confident support for AgmaVet®’s efficacy. As specified in a clinical trial published in the **Journal of Clinical Medicine** (2022), G-Agmatine® not only ameliorates OA-linked lameness but serves as a buffer against gastric ulcers, a prevalent side effect of conventional therapeutic strategies. This makes the supplement a promising and **safer alternative** in sustaining equine nerve health and agility. Further proving its potential, human trials reveal G-Agmatine®’s efficiency in expediting recovery from neuropathic pain, indicating a broad spectrum of neuroprotective applications extending to animals.

Product Composition and Usage

**AgmaVet® For Horses** is administered as a powder, with dosage adjustable to the horse’s needs—typically 1-2 scoops of 9 grams daily. Capsules are also available, ranging from 8-64 based on the horse's body weight, taken alongside meals or per veterinary advice. Notably, the product contains only **G-Agmatine®**, sans any allergens, preservatives, or additives. Mild gastrointestinal effects, like soft stools, are the rare exceptions to its generally side-effect-free profile. Gilad&Gilad clarifies the necessity of professional consultation for pregnant, nursing, ill, or medicated horses, underpinning the supplement’s customized application potential.

Shifting Paradigms in Animal Nutraceuticals

This innovative stride has ignited interest within the domain of animal nutraceuticals. Unlike pharmaceuticals that are limited in scope, nutraceuticals like G-Agmatine® bridge the gap, catering to both nerve health and joint mobility. Leadership skills of Gilad&Gilad are noteworthy, being the sole purveyors of **G-Agmatine®-based offerings** for animals. Continuous exploration of agmatine’s relevance in veterinary medicine could usher in further advancements in addressing osteoarticular afflictions.

Why AgmaVet® is a Game-Changer

The introduction of AgmaVet® For Horses marks a substantial evolution in offering holistic therapeutic options for horses grappling with joint and nerve issues. Horses benefit not just from an alleviation of symptoms but also improved quality of life and extended mobility. The dedication to **scientific validation and meticulous formulation processes** positions Gilad&Gilad as pioneers in unraveling multifaceted solutions for the equine world. To summarize, AgmaVet® For Horses paves a promising path towards advancing equine healthcare. Grounded in comprehensive research and thoughtful design, it emerges as a beacon of hope to offset the detrimental effects of osteoarticular concerns, offering a new lease of life for countless horses. For further details, see [Businesswire](https://www.businesswire.com/news/home/20260122904271/en/GiladGilad-Launches-Agmavet-for-Horses-for-Promoting-Resilient-Nerve-Functions-and-Joints-Mobility).